Previous close | 0.0025 |
Open | 0.0025 |
Bid | 0.0025 x 0 |
Ask | 0.0040 x 0 |
Day's range | 0.0025 - 0.0025 |
52-week range | 0.0015 - 0.0125 |
Volume | |
Avg. volume | 42,024 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...